1.Effects of the Liuzijue on post-stroke fatigue patients with the type of Qi deficiency and blood stasis
Xuemei LI ; Yanping LIU ; Junhua KE
Chinese Journal of Rehabilitation Medicine 2025;40(3):410-415
Objective:To observe the effect of Liuzijue on post-stroke fatigue patients with the type of Qi deficiency and blood stasis and the effect of pulmonary function.Method:From March 2022 to March 2023,a total of 68 post-stroke fatigue patients with Qi deficiency and blood stasis who were hospitalized in the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine and met the criteria were selected,the patients were divided into therapy group(n=34)and control group(n=34)according to random number table.The control group was treated with conventional reha-bilitation combined with conventional respiratory therapy,the therapy group was treated with conventional reha-bilitation combined with Liuzijue,30 minutes/time,5 times/week,a total of 12 weeks.The fatigue severity scale score(FSS),Qi Deficiency Syndrome and Blood Stasis factor diagnostic scale score,vital capacity(VC),forced vital capacity(FVC),peak expiratory flow(PEF),and maximal voluntary ventilation(MVV)were assessed in both groups before and after treatment.Result:After 12 weeks of treatment,the FSS scores and the Qi deficiency syndrome and blood stasis factor di-agnostic scale score exhibited significant differences in the therapy group compared with those before treatment(P<0.05),and significant improvement compared with those in the control group(P<0.05).The significant differ-ences were found in the VC、FVC、PEF and MVV of both two groups between before and after treatment(P<0.05),and the degree of improvement was more pronounced in the therapy group.Conclusion:The Liuzijue applied to post-stroke fatigue patients with Qi deficiency and blood stasis can better improve the fatigue score and Qi deficiency syndrome and blood stasis score,as well as improve the level of pulmonary function of patients,which is worthy of clinical application.
2.Effects of the Liuzijue on post-stroke fatigue patients with the type of Qi deficiency and blood stasis
Xuemei LI ; Yanping LIU ; Junhua KE
Chinese Journal of Rehabilitation Medicine 2025;40(3):410-415
Objective:To observe the effect of Liuzijue on post-stroke fatigue patients with the type of Qi deficiency and blood stasis and the effect of pulmonary function.Method:From March 2022 to March 2023,a total of 68 post-stroke fatigue patients with Qi deficiency and blood stasis who were hospitalized in the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine and met the criteria were selected,the patients were divided into therapy group(n=34)and control group(n=34)according to random number table.The control group was treated with conventional reha-bilitation combined with conventional respiratory therapy,the therapy group was treated with conventional reha-bilitation combined with Liuzijue,30 minutes/time,5 times/week,a total of 12 weeks.The fatigue severity scale score(FSS),Qi Deficiency Syndrome and Blood Stasis factor diagnostic scale score,vital capacity(VC),forced vital capacity(FVC),peak expiratory flow(PEF),and maximal voluntary ventilation(MVV)were assessed in both groups before and after treatment.Result:After 12 weeks of treatment,the FSS scores and the Qi deficiency syndrome and blood stasis factor di-agnostic scale score exhibited significant differences in the therapy group compared with those before treatment(P<0.05),and significant improvement compared with those in the control group(P<0.05).The significant differ-ences were found in the VC、FVC、PEF and MVV of both two groups between before and after treatment(P<0.05),and the degree of improvement was more pronounced in the therapy group.Conclusion:The Liuzijue applied to post-stroke fatigue patients with Qi deficiency and blood stasis can better improve the fatigue score and Qi deficiency syndrome and blood stasis score,as well as improve the level of pulmonary function of patients,which is worthy of clinical application.
3.Advances in the study of the human microbiome in renal cell carcinoma
Kangli MA ; Yaorong LI ; Weiguang ZHAO ; Zhixian YAO ; Zhong ZHENG ; Junyao XU ; Junhua ZHENG ; Ke WU
Chinese Journal of Urology 2024;45(9):718-721
Renal cell carcinoma is one of the significant diseases endangering human health. Recent findings have shown that the human microbiome plays an important role in the occurrence and development of renal cell carcinoma, influencing its regression and treatment outcome. At present, microecological research on renal cell carcinoma are still in their initial stages, and their regulatory roles and specific mechanisms still need to be further explored. This article reviews the relationship between the human microbiome and renal cell carcinoma occurrence and development, as well as its role in diagnosis and therapies.
4.Performance evaluation of serum progesterone measurement by ID-LC/MS/MS candidate reference methods and their clinical application value
Fen OUYANG ; Qiaoxuan ZHANG ; Jun YAN ; Liqiao HAN ; Jianbing WANG ; Peifeng KE ; Junhua ZHUANG ; Xianzhang HUANG
Chinese Journal of Laboratory Medicine 2022;45(5):456-462
Objective:To establish a candidate reference method for serum progesterone using isotope dilution liquid chromatography tandem mass spectrometry (ID-LC/MS/MS) in our laboratory, validate the analytic performance of five clinical routine detection systems to explore the comparability of serum progesterone detection by different detection systems.Methods:A candidate reference method for serum progesterone using ID-LC/MS/MS method was established. The sample was pretreated by liquid-liquid extraction method, and the reversed phase liquid phase separation in positive ion mass spectrometry mode was used to detect progesterone in human serum, and the detection time of a single sample was controlled within 5 minutes by gradient elution. In order to improve the accuracy of the method, the bracketing calibration method (BCM) was used to establish the standard curve. The sensitivity, accuracy, precision and specificity of BCM and classical calibration curve method were evaluated according to CLSI C62-A, EP15-A2, EP6-A2 and EP9-A3, and the analytical performance and comparability of five clinical routine progesterone detection systems were evaluated,compared with ID-LC/MS/MS method, the bias at medical decision level 2 and 25 ng/ml was evaluated to see if they were <1/2TEa (12.5%).Results:The limit of detection (LOD) of ID-LC/MS/MS was 0.005 ng/ml. The recoveries of BCM method and classical calibration curve method are 97.95%-101.58% and 96.88%-110.70%, respectively. The measurement results of BCM method for certified reference materials are within its declared uncertainty range. The intra-and inter-assay coefficient of variation ( CV) of BCM method was less than 3.0%, which was better than that of classical calibration curve method ( CV: 2.48%-9.33%). The precision and linear range of the five clinical routine detection systems can meet the detection requirements. The measurement bias of detection system 1, 3 and 5 at 25 ng/ml of medical decision level was less than 1/2TEa, and the measurement bias at 2 ng/ml of medical decision level was more than 1/2TEa. The measurement bias of detection system 2 and 4 at two medical decision levels was less than 1/2TEa. Conclusion:The candidate reference method for serum progesterone ID-LC/MS/MS established in our laboratory meets the requirements of the reference method. BCM has better detection performance than classical calibration curve method. The precision and linearity of the five progesterone clinical detection systems are satisfactory. The five clinical detection systems could meet the clinical requirements at the medical determination level of 25 ng/ml, however, only two of the five clinical detection systems meet the clinical requirements at the medical determination level of 2 ng/ml.
5.Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension.
Huai-Yu WANG ; Suyuan PENG ; Zhanghui YE ; Pengfei LI ; Qing LI ; Xuanyu SHI ; Rui ZENG ; Ying YAO ; Fan HE ; Junhua LI ; Liu LIU ; Shuwang GE ; Xianjun KE ; Zhibin ZHOU ; Gang XU ; Ming-Hui ZHAO ; Haibo WANG ; Luxia ZHANG ; Erdan DONG
Frontiers of Medicine 2022;16(1):102-110
Consecutively hospitalized patients with confirmed coronavirus disease 2019 (COVID-19) in Wuhan, China were retrospectively enrolled from January 2020 to March 2020 to investigate the association between the use of renin-angiotensin system inhibitor (RAS-I) and the outcome of this disease. Associations between the use of RAS-I (angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB)), ACEI, and ARB and in-hospital mortality were analyzed using multivariate Cox proportional hazards regression models in overall and subgroup of hypertension status. A total of 2771 patients with COVID-19 were included, with moderate and severe cases accounting for 45.0% and 36.5%, respectively. A total of 195 (7.0%) patients died. RAS-I (hazard ratio (HR)= 0.499, 95% confidence interval (CI) 0.325-0.767) and ARB (HR = 0.410, 95% CI 0.240-0.700) use was associated with a reduced risk of all-cause mortality among patients with COVID-19. For patients with hypertension, RAS-I and ARB applications were also associated with a reduced risk of mortality with HR of 0.352 (95% CI 0.162-0.764) and 0.279 (95% CI 0.115-0.677), respectively. RAS-I exhibited protective effects on the survival outcome of COVID-19. ARB use was associated with a reduced risk of all-cause mortality among patients with COVID-19.
Angiotensin Receptor Antagonists/therapeutic use*
;
Angiotensin-Converting Enzyme Inhibitors/therapeutic use*
;
COVID-19
;
Humans
;
Hypertension/drug therapy*
;
Renin-Angiotensin System
;
Retrospective Studies
6.Relationship Between Maximum Standardized Uptake Value of 18F-FDG PET/CT and Clinical Features of Tongue Squamous Cell Carcinoma
Dong ZHENG ; Lixuan NIU ; Jiahe TIAN ; Ke LI ; Junhua LIU ; Jun FEI
Chinese Journal of Medical Imaging 2017;25(7):481-486
Purpose To investigate the relationship between maximum standardized uptake value (SUVmax) of 18F-FDG PET/CT and clinical features of tongue squamous cell carcinoma (TSCC),in order to provide better PET/CT results for clinical guide.Materials and Methods Fifty-two patients with pathologically confirmed TSCC who accepting PET/CT examination before surgery were retrospectively analyzed.Single-factor analysis and multiple regression analysis were conducted on possible factors influencing primary tumor SUVmax,including gender,age,smoking history,tumor location,tumor size,TNM stage,T stage and N stage.Results Single-analysis showed that SUVmax was correlated with gender,tumor location,tumor size,TNM stage,T stage and N stage (P<0.05),and was not correlated with tumor differentiation,smoking history and age (P>0.05).Multivariate linear regression analysis showed that gender,tumor location,tumor size,T stage and N stage were independent influencing factors of primary tumor SUVmax (P<0.05).Primary tumor SUVmax had predictive value for lymph node metastasis.When the cutoff value was 6.57,the diagnostic efficiency was the highest,the sensitivity was 79.2% and the specificity was 85.7%.Conclusion TSCC 18F-FDG PET/CT SUVmax is higher among male patients with tongue base tumor location,larger tumor size and lymph node metastasis.Primary tumor SUVmax is of important significance in predicting lymph node metastasis.
7.The expression changes of cancer-related pathways genes screened by RT-PCR Array in bladder cancer
Ke YANG ; Bin FU ; Yibing WANG ; Gongxian WANG ; Junhua LI ; Rensheng LIU ; Xueliang QI ; Liang HUANG
China Oncology 2015;(7):505-510
Background and purpose:Bladder cancer is the most common urological tumor, and its pathogen-esis is still not fully understood. The study was aimed to observe the expressions of key genes in many tumor-associated signaling pathways in normal bladder tissue and bladder carcinoma, and to provide further evidence for the subsequent study of bladder cancer recurrence and metastasis.Methods:Twenty-seven cases of bladder cancer specimens were col-lected, and normal bladder tissues and bladder cancer tissues were distinguished by frozen section. Then, the expressions of 84 genes of cancer-related signaling pathways in bladder cancer tissues and normal bladder tissues were screened by Cancer Pathway Finder PCR Array produced by QIAGEN company.Results:Compared with the normal bladder tissues, the bladder carcinoma tissues had 8 up-regulated genes and 19 down-regulated genes. In this study, the impact of epithe-lial-mesenchymal transition (EMT) signaling pathway was selected as a research direction in which theGSC,KRT14,DSP were up-regulated,SNAI2,SNAI3 were down-regulated. ThereforeGSC,KRT14,DSP,SNAI2 andSNAI3 were chosen as target genes, and verified by qRT-PCR in many examples. The result showed that the expressions ofGSC gene in bladder cancer tissues were up-regulated, but with no statistical significance;KRT14,DSP expressions in bladder cancer were higher than those in normal bladder tissues (P<0.05);SNAI2,SNAI3 expressions in bladder cancer were lower than those in normal bladder tissues (P<0.05), andSNAI3 showed the most obvious expression differences.Conclusion:KRT14,DSP andSNAI3 may play an important role in bladder cancer’s occurrence, development and metastasis.
8.Oxidized low density lipoprotein stimulated endothelial nitric oxide by activating lectin-like oxidized-LDL receptor
Yaqin XU ; Junhua ZHANG ; yang KE ; jing CAO ; Tao NING ; Liya FENG ; Chaoshu TANG
Journal of Peking University(Health Sciences) 2001;33(2):150-152
Objective:To explore the role of lectin-like oxidized low density lipoprotein (ox-LDL) receptor(LOX1) in ox-LDL stimulating endothelial nitric oxide(NO) production. Methods: LOX1 mRNA expression was detected by reverse transcription-polymerase chain reaction(RT-PCR). The quantity of NO was detected by Enzyme-method. Results: Incubation of ox-LDL increased endothelial NO production and LOX1 mRNA expression. When HUVECs were incubated with ox-LDL as well as the inhibitor of LOX1, polyinosinic acid,the increase of NO production and LOX1mRNA expression were attenuated. Conclusion: Ox-LDL enhanced endothelial NO production in a concentration-dependent manner, and the effect of ox-LDL on endothelial NO was mediated by LOX1.

Result Analysis
Print
Save
E-mail